Luca Boldrini Selected Research

Luca Boldrini Research Topics

Disease

25	Rectal Neoplasms (Rectal Cancer) 03/2024 - 04/2018
19	Neoplasms (Cancer) 11/2023 - 03/2018
9	Breast Neoplasms (Breast Cancer) 05/2024 - 08/2019
8	Pancreatic Neoplasms (Pancreatic Cancer) 12/2023 - 04/2019
6	Neoplasm Metastasis (Metastasis) 05/2024 - 01/2020
6	Prostatic Neoplasms (Prostate Cancer) 10/2023 - 04/2021
6	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2022 - 12/2020
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2021
5	COVID-19 01/2022 - 01/2020
4	Head and Neck Neoplasms (Head and Neck Cancer) 01/2023 - 01/2021
3	Lung Neoplasms (Lung Cancer) 11/2023 - 07/2021
3	Sarcoma (Soft Tissue Sarcoma) 07/2021 - 01/2020
2	Renal Cell Carcinoma (Grawitz Tumor) 12/2023 - 12/2021
2	Pelvic Neoplasms 01/2023 - 01/2020
2	Pain (Aches) 07/2022 - 08/2019
2	Brain Neoplasms (Brain Tumor) 01/2022 - 01/2022
2	Pathologic Complete Response 12/2020 - 11/2018
1	Hodgkin Disease (Hodgkin's Disease) 04/2023
1	Dyspnea (Shortness of Breath) 01/2023
1	Crohn Disease (Crohn's Disease) 01/2023
1	Tachypnea 01/2023
1	Ovarian Neoplasms (Ovarian Cancer) 01/2023
1	Ventricular Tachycardia 01/2023
1	Endometrial Neoplasms (Endometrial Cancer) 11/2022
1	Heel Spur (Heel Spurs) 07/2022
1	Bullous Pemphigoid (Pemphigoid) 06/2022
1	Blister (Bulla) 06/2022
1	Congenital Abnormalities (Deformity) 06/2022
1	Radiation Injuries (Radiation Sickness) 01/2022
1	Trismus (Lockjaw) 01/2022
1	Esophageal Neoplasms (Esophageal Cancer) 07/2021
1	Hepatocellular Carcinoma (Hepatoma) 07/2021
1	Colonic Neoplasms (Colon Cancer) 01/2020
1	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2019
1	Thyroid Neoplasms (Thyroid Cancer) 01/2018
1	Macular Degeneration (Age-Related Maculopathy) 12/2017
1	Uveal melanoma 12/2017
1	Melanoma (Melanoma, Malignant) 06/2017

Drug/Important Bio-Agent (IBA)

4	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2023 - 01/2020
3	Hormones (Hormone)IBA 05/2024 - 04/2022
3	human ERBB2 proteinIBA 05/2024 - 04/2022
3	Biomarkers (Surrogate Marker)IBA 06/2023 - 01/2021
2	Phenobarbital (Luminal)FDA Link 05/2024 - 11/2023
2	NAD (NADH)IBA 01/2022 - 01/2022
1	Oxygen (Dioxygen)IBA 01/2023
1	Dihydrotachysterol (AT 10)IBA 01/2023
1	Choline (Choline Chloride)IBA 10/2022
1	Fluorine-18IBA 08/2022
1	fluoroethylcholineIBA 08/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	cabozantinibIBA 12/2021
1	NivolumabIBA 12/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2020
1	Ruthenium-106IBA 12/2017

Therapy/Procedure

64	Radiotherapy 05/2024 - 06/2017
18	Neoadjuvant Therapy 06/2023 - 01/2020
10	Drug Therapy (Chemotherapy) 03/2024 - 01/2020
6	Chemoradiotherapy 01/2022 - 03/2018
5	Brachytherapy 08/2019 - 06/2017
4	Immunotherapy 12/2023 - 12/2021
4	Precision Medicine 11/2023 - 02/2019
4	Therapeutics 09/2022 - 08/2019
3	Re-Irradiation 05/2023 - 01/2020
1	Sutures (Suture) 06/2022
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2022
1	Lymph Node Excision (Lymph Node Dissection) 10/2021
1	Radiofrequency Ablation 07/2021
1	Salvage Therapy 03/2021
1	Adjuvant Radiotherapy 06/2018